(Q54353219)

28 May 2018

http://europepmc.org/abstract/MED/24820412

title

Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer. (English)

1 reference

28 May 2018

http://europepmc.org/abstract/MED/24820412

author

Bora Lim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Hee Jin Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

In Ah Park

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

So Yeon Park

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

An Na Seo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Yun Chai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

In Hye Song

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Na Eun Kim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Joo Young Kim

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jong Han Yu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Jin-Hee Ahn

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Gyungyub Gong

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

English

0 references

publication date

13 May 2014

1 reference

28 May 2018

http://europepmc.org/abstract/MED/24820412

published in

Breast Cancer Research and Treatment

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

615-623

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24820412%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-014-2983-x

2 June 2020

exact match

0 references

cites work

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Personalizing extent of breast cancer surgery according to molecular subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Multifocal breast cancer documented in large-format histology sections: long-term follow-up results by molecular phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybrid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Presenting features of breast cancer differ by molecular subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

HER2 molecular subtype is a dominant subtype of mammary Paget's cells. An immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X

Tumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-2983-X